Zobrazeno 1 - 10 of 16 pro vyhledávání: '"Kaori, Tomida"'
1
Usefulness of measuring temporal changes in physical activity levels using an accelerometer for prediction and early detection of postoperative complications after hepatectomy
Autor: Toru Miyake, Haruki Mori, Masatsugu Kojima, Masaji Tani, Hiroya Iida, Tomoyuki Ueki, Katsushi Takebayashi, Hiromitsu Maehira, Kaori Tomida, Sachiko Kaida, Tomoharu Shimizu
Publikováno v: HPB. 24:57-64
Background:This research aimed to determine whether patterns of temporal changes in activity levels can indicate postoperative complications following hepatectomy.
Methods:Between December 2016 and December 2019, 147 patients wore an acceleromet
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aef379f9bdad55a94f8d7fd5e50ed402
https://doi.org/10.1016/j.hpb.2021.05.011
Zobrazit plný text záznamu
3
Infiltration of CD4, CD8, CD56, and Fox-P3-positive lymphocytes in breast carcinoma tissue after neoadjuvant chemotherapy with or without trastuzumab1
Autor: Yuki Kawai, Satoshi Murata, Mitsuaki Ishida, Kaori Tomida, Masaji Tani, Ryoji Kushima, Naoko Itoi, Tsuyoshi Mori, Tomoko Umeda, Tomoharu Shimizu
Publikováno v: Breast Disease. 38:57-65
BACKGROUND: Trastuzumab (Tz) is assumed to prime antibody-dependent cellular cytotoxicity (ADCC); however, it remains unclear whether Tz therapy can clinically induce adaptive cellular immunity. OBJECTIVE: Adaptive Cellular Immune Effect of Tz Therap
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::dd8394b70612e8b4fef1d8f5f766e0fd
https://doi.org/10.3233/bd-180350
Zobrazit plný text záznamu
4
Infiltration of CD4, CD8, CD56, and Fox-P3-positive lymphocytes in breast carcinoma tissue after neoadjuvant chemotherapy with or without trastuzumab
Autor: Naoko Itoi, Tomoko Umeda, Mitsuaki Ishida, Satoshi Murata, Tsuyoshi Mori, Yuki Kawai, Kaori Tomida, Tomoharu Shimizu, Ryoji Kushima, Masaji Tani
Publikováno v: Breast disease. 39(1)
Trastuzumab (Tz) is assumed to prime antibody-dependent cellular cytotoxicity (ADCC); however, it remains unclear whether Tz therapy can clinically induce adaptive cellular immunity.Adaptive Cellular Immune Effect of Tz Therapy.This study included 29
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec772522ae7f9f2489a12c324f34dcc0
https://pubmed.ncbi.nlm.nih.gov/31815683
Zobrazit plný text záznamu
5
[Two Cases of Unresectable/Advanced Breast Cancer with Pathological Complete Response after Combination Chemotherapy with Pertuzumab. Trastuzumab, and Docetaxel]
Autor: Kaori, Tomida, Yuki, Kawai, Tsuyoshi, Mori, Mina, Kitamura, Hisataka, Kato, Sachiko, Sakai, Tomoharu, Shimizu, Tomoko, Umeda, Masahiro, Tatsumi, Kana, Shimada, Masaji, Tani
Publikováno v: Gan to kagaku ryoho. Cancerchemotherapy. 45(13)
Combination chemotherapy with pertuzumab, trastuzumab, and docetaxel is recommended as the first-line treatment for patients with HER2-positive unresectable or metastatic breast cancer. We report 2 cases of unresectable breast cancer for which pertuz
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::a1701360f9dbb18830a776281678f153
https://pubmed.ncbi.nlm.nih.gov/30692489
Zobrazit plný text záznamu
6
[A Case of Breast Metastasis of Eccrine Porocarcinoma]
Autor: Tsuyoshi, Mori, Mina, Kitamura, Kaori, Tomida, Yuki, Kawai, Sachiko, Sakai, Sachiko, Kaida, Toru, Miyake, Naomi, Kitamura, Hiroya, Akabori, Tsuyoshi, Yamaguchi, Hiromichi, Sonoda, Tomoharu, Shimizu, Shigeyuki, Naka, Masaji, Tani
Publikováno v: Gan to kagaku ryoho. Cancerchemotherapy. 43(12)
An 80's woman was diagnosed with eccrine porocarcinoma of the head in 2010.T he tumor was removed surgically but relapsed in the cervical and axillary lymph nodes 2 years later.The patient underwent surgery, and received systemic chemotherapy and rad
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::61ae542f7110ee0b951c9ab57f17cf80
https://pubmed.ncbi.nlm.nih.gov/28133207
Zobrazit plný text záznamu
7
The Kampo Medicine Goshajinkigan Prevents Neuropathy in Breast Cancer Patients Treated with Docetaxel
Autor: Tohru Tani, Kaori Tomida, Yoshihiro Kubota, Tomoko Umeda, Tsuyoshi Mori, Yuki Kawai, Hajime Abe
Publikováno v: Asian Pacific Journal of Cancer Prevention. 14:6351-6356
Background: Goshajinkigan (GJG) is used for the treatment of several neurological symptoms. We investigated the efficacy of GJG and mecobalamin (B12) against neurotoxicity associated with docetaxel (DOC) in breast cancer patients. Materials and Metho
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33131d97ed155991f4f3c9d60decbc2e
https://doi.org/10.7314/apjcp.2013.14.11.6351
Zobrazit plný text záznamu
8
Feasibility Study of Docetaxel and Cyclophosphamide Six- Cycle Therapy as Adjuvant Chemotherapy for Japanese Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Patients
Autor: Yoshihiro Kubota, Tsuyoshi Mori, Hajime Abe, Kaori Tomida, Tomoko Umeda, Tohru Tani, Yuki Kawai
Publikováno v: Asian Pacific Journal of Cancer Prevention. 14:4835-4838
Background: We compared treatment completion rates and safety of docetaxel and cyclophosphamide sixcycle therapy (TC6) with docetaxel followed by 5FU, epirubicin and cyclophosphamide (T-FEC) therapy in Japanese patients with human epidermal growth fa
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b7168e5c6a3caf0aa6221c3a9c3baa3
https://doi.org/10.7314/apjcp.2013.14.8.4835
Zobrazit plný text záznamu
9
Abstract P1-15-11: The Kampo medicine Goshajinkigan prevents docetaxel-related peripheral neuropathy in breast cancer patients
Autor: Hiroyuki Abe, Tsuyoshi Mori, Kaori Tomida, Hirotomi Cho, N Itoi, Yoshihiro Kubota, Yuki Kawai, Tohru Tani, Tomoko Umeda
Publikováno v: Cancer Research. 72:P1-15
Background: Although taxanes have become a key chemotherapeutic drug in breast cancer treatment. Taxanes inhibit the growth of cancer cells by disrupting the functioning of their microtubules; however, the microtubules of nerve cells are also affecte
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::83e3be1ce139c71221151f9d4efbc9d5
https://doi.org/10.1158/0008-5472.sabcs12-p1-15-11
Zobrazit plný text záznamu
10
Immunohistochemical analyses of CD44 variant isoforms in invasive micropapillary carcinoma of the breast: comparison with a concurrent conventional invasive carcinoma of no special type component
Autor: Akie Tanaka, Satoshi Murata, Tomoko Umeda, Kaori Tomida, Mina Kitamura, Sachiko Sakai, Mitsuaki Ishida, Ryoji Kushima, Yoshihiro Kubota, Yuki Kawai, Naoko Itoi, Tsuyoshi Mori, Masaji Tani
Publikováno v: Breast cancer (Tokyo, Japan). 23(6)
Invasive micropapillary carcinoma (IMPC) is a distinct histopathological variant of breast carcinoma and frequently develops lymph node metastases. CD44 is a family of transmembrane glycoprotein receptors with multiple variant isoforms (CD44v), which
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be22eb9848858ace29d5312df0621ae5
https://pubmed.ncbi.nlm.nih.gov/26494575
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje